G6PD deficiency and antimalarial efficacy for uncomplicated malaria in Bangladesh: A prospective observational study

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Ley, Benedikt ^a   Alam, Mohammad Shafiul ^b   Thriemer, Kamala ^a   Hossain, Mohammad Sharif ^b   Kibria, Mohammad Golam ^b   Auburn, Sarah ^a   Poirot, Eugenie ^c   Price, Ric N ^a,d   Khan, Wasif Ali ^b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b International Centre for Diarrheal Diseases and Research   (Bangladesh)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BENFLUMETOL; CHLOROQUINE; HEMOGLOBIN; PRIMAQUINE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; AGED; ARTICLE; BANGLADESH; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; MALARIA; MALARIA FALCIPARUM; MALE; MICROSCOPY; MIXED INFECTION; NONHUMAN; OBSERVATIONAL STUDY; PARASITE CLEARANCE; PARASITE IDENTIFICATION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; ANIMAL; CAT; COMPLICATION; GUINEA PIG; MALARIA, FALCIPARUM; MALARIA, VIVAX;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; BANGLADESH; CATS; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GUINEA PIGS; HUMANS; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE;

EID: 84966990566     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154015     Document Type: Article

References (46)

1. Haque U, Overgaard HJ, Clements AC, Norris DE, Islam N, Karim J et al. Malaria burden and control in Bangladesh and prospects for elimination: an epidemiological and economic assessment. The Lancet Global health. 2014; 2(2):e98-105. doi: 10.1016/S2214-109X(13)70176-1 PMID: 25104666
2. Starzengruber P, Fuehrer HP, Ley B, Thriemer K, Swoboda P, Habler VE et al. High prevalence of asymptomatic malaria in south-eastern Bangladesh. Malaria journal. 2014; 13:16. doi: 10.1186/1475-2875-13-16 PMID: 24406220
3. Maude RJ, Hasan MU, Hossain MA, Sayeed AA, Kanti Paul S, Rahman W et al. Temporal trends in severe malaria in Chittagong, Bangladesh. Malaria journal. 2012; 11:323. doi: 10.1186/1475-2875-11-323 PMID: 22970881
4. WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization2015.
5. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. The New England journal of medicine. 2008; 359(24):2619-20. doi: 10.1056/NEJMc0805011 PMID: 19064625
6. Noedl H, Se Y, Sriwichai S, Schaecher K, Teja-Isavadharm P, Smith B et al. Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2010; 51(11):e82-9. doi: 10.1086/657120
7. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. The Lancet infectious diseases. 2012; 12(11):851-8. doi: 10.1016/S1473-3099(12)70181-0 PMID: 22940027
8. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J et al. Artemisinin resistance in Plasmodium falciparum malaria. The New England journal of medicine. 2009; 361(5):455-67. doi: 10.1056/NEJMoa0808859 PMID: 19641202
9. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. The New England journal of medicine. 2014; 371(5):411-23. doi: 10.1056/NEJMoa1314981 PMID: 25075834
10. Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. The Lancet infectious diseases. 2016. doi: 10.1016/S1473-3099(15)00487-9
11. Thriemer K, Hong NV, Rosanas-Urgell A, Phuc BQ, Ha do M, Pockele E et al. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam. Antimicrobial agents and chemotherapy. 2014; 58(12):7049-55. doi: 10.1128/AAC.02746-14 PMID: 25224002
12. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012; 379 (9830):1960-6. doi: 10.1016/S0140-6736(12)60484-X PMID: 22484134
13. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. The Lancet infectious diseases. 2015; 15(4):415-21. doi: 10.1016/S1473-3099(15)70032-0 PMID: 25704894
14. Samad R, Rahman MR, Yunus EB, Hussain MA, Arif SM, Islam MN et al. An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh. Bangladesh Medical Research Council bulletin. 2013; 39(3):109-15. PMID: 26118157
15. Starzengruber P, Swoboda P, Fuehrer HP, Khan WA, Hofecker V, Siedl A et al. Current status of artemisinin-resistant falciparum malaria in South Asia: a randomized controlled artesunate monotherapy trial in Bangladesh. PloS one. 2012; 7(12):e52236. doi: 10.1371/journal.pone.0052236 PMID: 23272227
16. WHO. World Malaria Report 2015. 2015:157.
17. Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrobial agents and chemotherapy. 2004; 48(11):4075-83. doi: 10.1128/AAC.48.11.4075-4083.2004 PMID: 15504824
18. Price RN, von Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. The Lancet infectious diseases. 2014; 14(10):982-91. doi: 10.1016/S1473-3099(14)70855-2 PMID: 25213732
19. von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malaria journal. 2013; 12:112. doi: 10.1186/1475-2875-12-112. PMID: 23537118
20. Price RN. Improving the Radical Cure of Plasmodium vivax Malaria. The American journal of tropical medicine and hygiene. 2014. doi: 10.4269/ajtmh.14-0118
21. Shannon KL, Ahmed S, Rahman H, Prue CS, Khyang J, Ram M et al. Hemoglobin E and Glucose-6- Phosphate Dehydrogenase Deficiency and Plasmodium falciparum Malaria in the Chittagong Hill Districts of Bangladesh. The American journal of tropical medicine and hygiene. 2015. doi: 10.4269/ajtmh.14-0623
22. Alam MS, Chakma S, Khan WA, Glass GE, Mohon AN, Elahi R et al. Diversity of anopheline species and their Plasmodium infection status in rural Bandarban, Bangladesh. Parasites & vectors. 2012; 5:150. doi: 10.1186/1756-3305-5-150
23. Alam MS, Khan MG, Chaudhury N, Deloer S, Nazib F, Bangali AM et al. Prevalence of anopheline species and their Plasmodium infection status in epidemic-prone border areas of Bangladesh. Malaria journal. 2010; 9:15. doi: 10.1186/1475-2875-9-15 PMID: 20074326
24. Abul Barakat SH, Avijit Poddar, M.D. Baddiuzzaman, Asmar Osman, Md. Shahnewaz Khan, Matiur Rahman, Murtaza Majid, Golam Mahiyudin, Sushmita Chakma, Sharmina Bashir. Socio - Economic Baseline Survey of Chittagong Hill Tracts. Bangladesh: UNDP2009.
25. WHO. Methods for surveillance of antimalarial drug efficacy. 2009. http://whqlibdoc.who.int/publications/2009/9789241597531-eng.pdf. Accessed last accessed 05.03.2013.
26. WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2000; 94 Suppl 1:S1-90. PMID: 11103309
27. LaRue N, Kahn M, Murray M, Leader BT, Bansil P, McGray S et al. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. The American journal of tropical medicine and hygiene. 2014; 91(4):854-61. doi: 10.4269/ajtmh.14-0194 PMID: 25071003
28. Poirot E, Hwang J, Brown J, Gosling R. A Safety Monitoring Tool for Primaquine Use to Reduce Transmission of Plasmodium Falciparum - Abstratct 1277 In: Hygiene ASoTMa, editor. 62nd Annual Meeting November 13-17, 2013: ASTMH; 2013.
29. Banek K, Lalani M, Staedke SG, Chandramohan D. Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence. Malaria journal. 2014; 13:7. doi: 10.1186/1475-2875-13-7 PMID: 24386988
30. Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malaria journal. 2011; 10:339. doi: 10.1186/1475-2875-10-339 PMID: 22074219
31. Kaplan EL, Meier P. Nonparametric Estimation from Incomplete Observations. Journal of the American Statistical Association. 1958; 53(282):457-81. doi: 10.2307/2281868
32. Haque R, Thriemer K, Wang Z, Sato K, Wagatsuma Y, Salam MA et al. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh. The American journal of tropical medicine and hygiene. 2007; 76(1):39-41. PMID: 17255226
33. WWARN. Parasite Clearance Estimator. 2012. http://www.wwarn.org/research/parasite-clearance-estimator. Accessed April 2013.
34. Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malaria journal. 2013; 12:391. doi: 10.1186/1475-2875-12-391 PMID: 24188096
35. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bulletin of the World Health Organization. 1989; 67(6):601-11. PMID: 2633878
36. van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M et al. Efficacy of chloroquine + sulfadoxine - pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2005; 99(10):727-35. doi: 10.1016/j.trstmh.2005.02.007 PMID: 16095643
37. Rahman MM, Dondorp AM, Day NP, Lindegardh N, Imwong M, Faiz MA et al. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008; 102(9):861-7. doi: 10.1016/j.trstmh.2008.05.022 PMID: 18606428
38. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014; 505(7481):50-5. doi: 10.1038/nature12876 PMID: 24352242
39. Mita T, Tachibana S, Hashimoto M, Hirai M. Plasmodium falciparum kelch 13: a potential molecular marker for tackling artemisinin-resistant malaria parasites. Expert review of anti-infective therapy. 2016; 14(1):125-35. doi: 10.1586/14787210.2016.1106938 PMID: 26535806
40. Mohon AN, Alam MS, Bayih AG, Folefoc A, Shahinas D, Haque R et al. Mutations in Plasmodium falciparum K13 propeller gene from Bangladesh (2009-2013). Malaria journal. 2014; 13(1):431. doi: 10.1186/1475-2875-13-431
41. Khim N, Benedet C, Kim S, Kheng S, Siv S, Leang R et al. G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients. Malaria journal. 2013; 12:171. doi: 10.1186/1475-2875-12-171 PMID: 23714236
42. Leslie T, Moiz B, Mohammad N, Amanzai O, Ur Rasheed H, Jan S et al. Prevalence and molecular basis of glucose-6-phosphate dehydrogenase deficiency in Afghan populations: implications for treatment policy in the region. Malaria journal. 2013; 12(1):230. doi: 10.1186/1475-2875-12-230
43. Maiga B, Dolo A, Campino S, Sepulveda N, Corran P, Rockett KA et al. Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali. Malaria journal. 2014; 13:270. doi: 10.1186/1475-2875-13-270 PMID: 25015414
44. Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Meilia RA et al. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrobial agents and chemotherapy. 2013; 57 (3):1128-35. doi: 10.1128/AAC.01879-12 PMID: 23254437
45. Imbriani M, Melotti A, Ghittori S. Methemoglobin and carboxyhemoglobin levels in smokers and non smokers. Giornale italiano di medicina del lavoro. 1987; 9(1):11-4. PMID: 3505219
46. Graves PM, Gelband H, Garner P. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission. The Cochrane database of systematic reviews. 2015; 2:CD008152. doi: 10.1002/14651858.CD008152.pub4 PMID: 25693791